Essex Investment Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-6,563
Closed -$221K 393
2019
Q4
$221K Sell
6,563
-702
-10% -$25.4K 0.03% 361
2019
Q3
$272K Hold
7,265
0.04% 343
2019
Q2
$317K Sell
7,265
-10,141
-58% -$434K 0.04% 338
2019
Q1
$743K Sell
17,406
-200
-1% -$8.96K 0.11% 231
2018
Q4
$789K Buy
17,606
+2,962
+20% +$155K 0.12% 218
2018
Q3
$1M Buy
+14,644
New +$942K 0.12% 229

Other funds holding AVNS

Essex Investment Management's AVNS Position: Q1 2020 in Review

Essex Investment Management sold out of Avanos Medical (AVNS) in Q1 2020, closing a stake of 6,563 shares — an estimated $221K sold.

Essex Investment Management first reported a position in AVNS in Q3 2018 and held it in 6 quarters. The position peaked at $1M in Q3 2018. 272 funds tracked by Wall St. Rank hold AVNS as of Q1 2020.

  • Essex Investment Management reported no remaining Avanos Medical position as of Q1 2020 after selling out during the quarter.
  • Essex Investment Management sold 6,563 Avanos Medical shares in Q1 2020, an estimated $221K.
  • Essex Investment Management first reported a position in Avanos Medical in Q3 2018 and held it in 6 quarters.
  • Essex Investment Management's Avanos Medical position peaked at $1M in Q3 2018.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2020.

Based on Essex Investment Management's 13F filing for Q1 2020, filed 4 May 2020.